Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
Therapeutic synergies that overcome carboplatin resistance in triple-negative breast cancer.
PMID 41630032 · PMC13037280 · Journal of experimental & clinical cancer research : CR · 2026 · 8 claims · 8 setups
Four isogenic carboplatin-resistant (CR) PDX pairs (WHIM30, BCM-2147, BCM-3887, BCM-7482) were generated via serial in vivo carboplatin exposure to model acquired resistance in TNBC
-
Full-text index only
Identification of Molecular Subtypes of Clear-Cell Renal Cell Carcinoma in Patient-Derived Xenografts Using Multi-Omics.
PMID 40282537 · PMC12026142 · Cancers · 2025 · 8 claims · 7 setups
Each ccRCC PDX resembles one of the human molecular subtypes closely at both the transcript and protein levels.
-
Full-text index only
Multimodal profiling of pancreatic cancer reveals a TIMP-1-dominated secretory profile determining pro-tumor immunoinstruction in human cancers.
PMID 41564862 · PMC12866174 · Cell reports. Medicine · 2026 · 8 claims · 8 setups
A 19-factor cancer-immunoinstructive secretory signature (CISS) is present across multiple human cancers and correlates with pro-tumorigenic tumor microenvironments and poor patient survival.
-
Full-text index only
Synergistic targeting of eIF4A-mediated translation initiation and apoptosis in acute myeloid leukemia.
PMID 41815287 · PMC12971725 · Blood neoplasia · 2026 · 8 claims · 8 setups
EIF4A1 is highly expressed in AML stem- and progenitor-like cells relative to healthy hematopoietic stem/progenitor cells
-
Full-text index only
Critical evaluation of drug response prediction models with DrEval.
PMID 42120410 · PMC13168506 · Nature communications · 2026 · 8 claims · 6 setups
DrEval is a living open-source benchmarking pipeline for unbiased, biologically meaningful evaluation of cancer drug response prediction models, integrating standardized preprocessing, hyperparameter tuning, statistically rigorous evaluation, cross-study benchmarks, and ablation studies.
-
Full-text index only
Targeting the Lipid Metabolism Proteins FASN and GPAM in Alveolar Type II Cells Decreases Lung Metastasis.
PMID 41778850 · PMC7619144 · Cancer discovery · 2026 · 7 claims · 8 setups
AT2 cells and surfactant lipids (e.g., PC, PE, PI, PG) are enriched in the vicinity of breast cancer lung metastases in both patients and mice